Status: Recruiting
Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.
The aim of this study is to compare the cost effectiveness of Sulfonylureas and DPP4-inhibitors in combination with Metformin among type2 diabetic patients diagnosed for 2-5 years. Glycemic status and other clinical outcome are compared in between two groups and ICER are compared.
Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshUpdated: Aug 26, 2024Locations: 1
Eligibility criteria
New onset type2 diabetes mellitus diagnosed for 2 -5 years. [+4]
Unwillingness to participate or unwillingness to give written informed consent. [+3]